Login / Signup

Treatment with obinutuzumab leads to worse outcomes in haematological patients diagnosed with Omicron variant COVID-19.

Tali ShafatDaniel GrupelTzvika PorgesItai LeviYael YagelLior Nesher
Published in: British journal of haematology (2022)
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • sars cov
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • metabolic syndrome
  • adipose tissue
  • combination therapy
  • insulin resistance